Last updated: April 24, 2026
Who Supplies EUCRISA (crisaborole) and Its Key Commercial Inputs?
EUCRISA is crizaborole (often misread as “crisaborole” in shorthand). It is a topical phosphodiesterase-4 (PDE4) inhibitor indicated for plaque psoriasis. Public sourcing details for the full supply chain (API, key intermediates, drug product manufacturing, and packaging) are not consistently disclosed in a way that supports a complete, accurate supplier-by-supplier list based on verifiable primary records.
What Supplier List Can Be Stated Reliably from Public Record?
Publicly verifiable records do not provide a complete, non-overlapping supplier roster for EUCRISA across:
- API (crizaborole) manufacture and key intermediate suppliers
- drug substance purification and polymorph control
- drug product (topical formulation) manufacturing
- secondary packaging and distribution
As a result, a complete supplier list would require non-public data or redacted regulatory submissions that are not consistently available in the public domain.
Which Suppliers Are Typically Named for EUCRISA in Public Regulatory/Labeling Assets?
When EU medicines are supported by public label and regulatory summaries, supplier names usually appear only for:
- Marketing authorization holder (MAH) and sometimes
- local manufacturing sites (not always the same as the API source)
For EUCRISA specifically, the supplier-by-supplier mapping for the entire chain is not fully available in an auditable way in public materials.
What Can Be Used as Actionable Supplier Inputs Without Breaking Accuracy?
A business-valid approach in this category is to separate:
- MAH and product-manufacturing site identifiers (where publicly named)
from
- API and intermediate suppliers (often hidden behind corporate sourcing and not fully disclosed)
For EUCRISA, the available public evidence supports only partial identification, not a full supplier roster.
Market-Use Implication: Why Incomplete Supplier Disclosure Matters for Procurement
For topical small-molecule brands like EUCRISA, supply risk often concentrates in:
- API synthesis route and impurity profile control
- drug substance particle/grade consistency
- formulation excipient availability for topical creams/ointments
- packaging format compliance (tube/closure systems)
Publicly available information usually does not name the underlying API or excipient suppliers, so procurement due diligence typically relies on:
- qualified manufacturing site records
- GMP batch documentation access
- vendor qualification dossiers
Key Takeaways
- A fully verifiable, supplier-by-supplier list for EUCRISA supply (API, intermediates, drug product manufacturing, and packaging) is not available in the public record in a complete form.
- Public assets usually support only partial identification (commonly MAH and sometimes manufacturing sites), not the full chain.
- For R&D or investment diligence, EUCRISA supplier discovery must be treated as a qualification exercise anchored to GMP site documentation rather than expecting public supplier disclosure.
FAQs
1) Who manufactures EUCRISA drug product in Europe?
Public sourcing is typically limited to named manufacturing sites where present in labeling/regulatory assets; a complete site list is not consistently available in public documentation.
2) Who supplies the EUCRISA API (crizaborole)?
The API supplier is not reliably disclosed in public records in a way that supports a complete supplier list.
3) Are excipient suppliers publicly listed for EUCRISA?
Excipient suppliers are generally not fully enumerated in public regulatory or label materials for this product.
4) Does the marketing authorization holder equal the manufacturing supplier?
No. The MAH may outsource manufacturing to one or more contract manufacturing organizations.
5) Where can supplier information be validated for procurement?
Through qualified GMP site documentation and batch release/quality agreements tied to the named manufacturing sites and internal supplier qualification.
References (APA)
[1] European Medicines Agency. (n.d.). EUCRISA (crizaborole) product information and assessment materials. EMA. https://www.ema.europa.eu/ (Search “EUCRISA crizaborole”)
